The global interventional cardiology devices market size was estimated at USD 10.57 billion in 2024 and is projected to reach USD 19.75 billion by 2033, growing at a CAGR of 7.25% from 2025 to 2033. Market growth is primarily driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and ongoing technological advancements, including the development of drug-eluting stents and bioresorbable vascular scaffolds.

The expanding elderly population, rising healthcare spending, and improved access to cardiac care in emerging markets further contribute to market expansion. Continuous product innovation, coupled with the integration of artificial intelligence (AI) and advanced imaging techniques in catheter-based interventions, is enhancing procedural accuracy and patient outcomes, thereby fueling demand for interventional cardiology devices.

The increasing prevalence of cardiovascular diseases remains a primary market driver. Sedentary lifestyles, unhealthy dietary habits, and rising rates of obesity and diabetes have led to a global surge in coronary artery disease and other cardiac conditions. This growing disease burden has increased the need for timely and effective interventions, driving the adoption of stents, catheters, and other interventional tools.

According to the U.S. Centers for Disease Control and Prevention (CDC) in October 2024, heart disease continues to be the leading cause of death in the U.S., accounting for more than 919,000 fatalities in 2023, which represents roughly one-third of all deaths. On average, a person dies from cardiovascular disease every 34 seconds, and approximately 5% of adults are affected by coronary artery disease. Between 2020 and 2021, heart disease imposed a significant economic burden, resulting in USD 417.9 billion in healthcare costs, medications, and lost productivity.

Key Market Trends & Insights:

• The North America interventional cardiology devices market dominated the global market in 2024, accounting for the largest revenue share of 45.06%. This leadership reflects the region’s advanced healthcare infrastructure, high prevalence of cardiovascular diseases, well-established reimbursement policies, and widespread adoption of minimally invasive cardiac procedures. The presence of key market players and the continuous development of innovative interventional cardiology solutions further reinforce North America’s dominant position.

• The Asia Pacific interventional cardiology devices market is anticipated to register the fastest growth rate during the forecast period. Factors contributing to this rapid expansion include increasing healthcare expenditure, improving access to cardiac care, a growing elderly population, and rising awareness about cardiovascular health. Emerging economies in the region are witnessing a surge in demand for advanced cardiac interventions, making it a key growth market for interventional cardiology devices.

• In terms of product segmentation, the coronary stents segment held the largest revenue share in 2024. Coronary stents are widely utilized in the treatment of coronary artery disease due to their proven efficacy in restoring blood flow and reducing the risk of cardiac events. Among coronary stents, the drug-eluting stents (DES) segment accounted for the largest revenue share in 2024. DES are preferred for their ability to release medication that prevents restenosis, enhancing long-term outcomes and improving patient prognosis. Their widespread adoption across hospitals and cardiac centers underscores their importance within the interventional cardiology devices market.

Order a free sample PDF of the Interventional Cardiology Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 10.57 Billion

• 2033 Projected Market Size: USD 19.75 Billion

• CAGR (2025-2033): 7.25%

• North America: Largest market in 2024

• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

Key participants in the interventional cardiology devices market are actively focusing on developing innovative strategies to drive business growth and strengthen their competitive positions. These strategies include expanding product portfolios by introducing advanced and diversified device offerings, forming strategic partnerships and collaborations with technology providers, research institutions, and healthcare organizations to leverage expertise and access new markets, and engaging in mergers and acquisitions to enhance capabilities, achieve economies of scale, and broaden market reach. Additionally, companies are working on expanding their business footprint across emerging and established regions to capture new growth opportunities and improve accessibility of their products.

Key Players

• Abbott

• Medtronic plc

• Boston Scientific Corporation

• Cardinal Health, Inc.

• Koninklijke Philips N.V.

• Terumo Corporation

• Alvimedica Medical Technologies Inc.

• Teleflex Incorporated

• B. Braun Melsungen AG

• Biosensors International Group, Ltd.

• Meril Life Sciences Pvt. Ltd.

• BIOTRONIK SE & Co. KG

• ACIST Medical Systems, Inc.

• Asahi Intecc Co., Ltd.

• Cook Medical LLC

• Medinol Ltd.

• Merit Medical Systems, Inc.

• NuMED, Inc.

• OpSens Inc.

• Zeon Medical Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

In conclusion, the global interventional cardiology devices market is expected to grow steadily over the forecast period, driven by the rising prevalence of cardiovascular diseases and increasing demand for minimally invasive cardiac procedures. Technological advancements—such as improvements in stent technology and catheter based interventions—along with expanding healthcare infrastructure and greater access to cardiac care in emerging regions, are supporting this growth. The market is also benefiting from continuous product innovation, integration of advanced imaging and AI, and strategic efforts by key players to enhance their offerings and geographic reach, reflecting a positive long term outlook for industry expansion.